Paul F Miller

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Microbial Community

Bacillus Subtilis

Top Venues

Molecular medicine (Cambridge, Mass.)

Nature reviews. Drug discovery

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Paul F Miller
Targeting microbial pathogenic mechanisms as a novel therapeutic strategy in IBD. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Paul F Miller
Targeting microbial pathogenic mechanisms as a novel therapeutic strategy in IBD. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Paul F Miller
Targeting microbial pathogenic mechanisms as a novel therapeutic strategy in IBD. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Andres Cubillos-Ruiz, Tingxi Guo, Anna Sokolovska, Paul F Miller, James J Collins, Timothy K Lu, Jose M Lora
Engineering living therapeutics with synthetic biology. Nature reviews. Drug discovery 20 (12) (2021)
Caroline B Kurtz, Yves A Millet, Marja K Puurunen, Mylène Perreault, Mark R Charbonneau, Vincent M Isabella, Jonathan W Kotula, Eugene Antipov, Yossi Dagon, William S Denney, David A Wagner, Kip A West, Andrew J Degar, Aoife M Brennan, Paul F Miller
An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Science translational medicine 11 (475) (2020)